Creating a drug's safety profile through the use of benefit-risk assessments during development.
J. Rick Turner, PhD
Advertisement
Articles by J. Rick Turner, PhD
Centralized approach for Phase III studies enhances the quality and integrity of collected data.
Advertisement
Latest Updated Articles
Integrated Drug SafetyPublished: June 1st 2011 | Updated:
The Science of Cardiac SafetyPublished: November 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
AI in Action: Breaking Down Clinical Trial Bottlenecks
4
Unlocking the Potential of Agentic AI to Reduce Trial Delays
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
